Ad
related to: emcure pharmaceuticals share price moneycontrol
Search results
Results From The WOW.Com Content Network
Emcure Pharmaceuticals was established in 1981 by Satish Mehta, who began the company with a bank loan of ₹ 3 lakh (about US$35,000 then) after graduating from IIM-A. [9] In the 1990s, the company transitioned from being a contract manufacturing organization to a producer of generic drugs .
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Namita Thapar (née Mehta; born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. [1] She is the Executive director of Emcure Pharmaceuticals. [2]
Indian generic drugmaker Emcure Pharmaceuticals and U.S. vaccine developer HDT Bio have settled allegations that Emcure stole HDT trade secrets during their joint work on a COVID-19 shot, the ...
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. [5] [6] [7] As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in ...
Over the course of two days, the BSE SENSEX in India dropped from 19,013 on Monday morning to 16,730 by Tuesday evening or a two-day fall of 13.9%. [66] Less than a month later, on 11 February 2008, the SENSEX lost 833.98 points, when Reliance Power fell below its IPO price in its debut trade after a high-profile public offer. [32]
I have just modified 4 external links on Emcure Pharmaceuticals. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
On 20 September 2011, [6] the equity shares of Alembic Pharmaceuticals post its demerger from Alembic Ltd. got listed on the Bombay Stock Exchange [10] where it is a constituent of BSE 500 index and on the National Stock Exchange of India [11] where it is a constituent of Nifty 500 index.